We employ broadband dielectric spectroscopy to study the relaxation dynamics and crystallization kinetics of a broad-spectrum antibiotic, chloramphenicol, in its supercooled liquid form. Two dynamic processes are observed: the structural α relaxation, which becomes kinetically frozen at T g = 302 ± 1 K, and an intramolecular secondary relaxation. Under isothermal conditions, the supercooled drug displays interconversion between different isomers, followed by recrystallization. Recrystallization follows the Avrami law with Avrami exponent n = 1.3 ± 0.1, consistent with a one dimensional growth of crystalline platelets, as observed by electron microscopy. Exposure to humid atmosphere and subsequent heating to high temperature is found to degrade the compound. The partially degraded sample displays a much lower tendency to crystallize, likely because the presence of the degradation products results in spatial frustration. This sample exhibits enhanced conductivity and an additional relaxation, intermediate to the ones observed in the pure sample, which likely corresponds to the noncooperative dynamics of the main degradation product. We find that dispersing the antibiotic in polylactic acid results in an amorphous sample which does not crystallize at room temperature for relatively long times.
Introduction
Chloramphenicol (hereafter CAP, inset of Figure 1 ) is a broad-spectrum antibiotic used as a treatment for a number of bacterial infections. Although it had previously fallen into disuse due to limitations on the amount that can be applied not to cause systemic toxicity, it has become an alternative to treat multi-drug-resistant bacteria and has been recently suggested as a potential anticancer drug. 1, 2 CAP blocks protein growth, inhibiting peptide bond formation by binding to a peptidyl transferase enzyme of the bacterial ribosome, which prevents the transfer of aminoacids to the growing peptide chain. Thanks to this general mechanism, it proved effective against Gram-positive as well as Gram-negative (e.g. rickettsiae) bacteria. 3 CAP is hydrophobic, and shows a low aqueous solubility which limits its absorption rate. If a drug cannot be dissolved in biological fluids fast enough, it does not reach the absorption site and thus it does not trigger the desired biological response. Unfortunately, most drugs are poorly water-soluble, so that additional strategies must be employed to enhance their bioavailability. 4 Of the various possible approaches to enhance the solubility of active pharmaceutical ingredients, amorphization offers the advantage that it does not require chemical modification of the drug. Solid amorphous (glassy) pure drugs have a proven higher solubility in vivo as well as better dissolution profiles compared with the crystalline form of the drug. 5, 6, 7, 8, 9, 10, 11, 12 This is because the dissolution process is governed by the difference in Gibbs free energy of the initial and final state, i.e., between the separated components and the dissolved state, and the glassy state has higher free energy than the crystalline state, so that dissolution requires less energy, resulting in better rates of uptake by the organism. Several drugs with poor aqueous solubility have reached the drug development stage formulated as amorphous phase. 13, 14 On the other hand, glasses are thermodynamically unstable due precisely to their excess in free energy, entropy, and enthalpy, and are therefore susceptible to convert into the more stable and less soluble crystalline phase (by "recrystallization"). A large number of factors (such as preparation method, thermal and mechanical treatments employed during formulation, storage temperature, application of pressure or exposure to humidity, and even the choice of container material) may influence the kinetic stability of the glassy phase, 15, 16, 17 and the microscopic mechanism governing metastability remains unclear. The two main aspects governing recrystallization are thermodynamics and molecular kinetics. 18 The latter is known to influence the crystallization rate: 19, 20 for example, storage well below the glass transition temperature T g (in fact, below the vitrification temperature of whole-molecule secondary relaxations) prevents recrystallization 21, 22 because, despite the fact that at such relatively low temperature the freeenergy difference between the crystalline and glassy phases (thermodynamic drive) is very large, the molecular mobility is too low for nucleation and growth of the crystalline phase to take place.
In this context, it is important to identify, among drugs with low water solubility such as CAP, those which have sufficiently low recrystallization rate at room temperature so that they can be stored in glassy form for a convenient period of time. It is also interesting to devise strategies to improve the physical stability of those which instead tend to recrystallize from their amorphous state over short times. In the case of CAP, a recent study by means of broadband dielectric spectroscopy 23, 24 has shown that the amorphous phase of CAP can be heated to and maintained at temperatures well above its glass transition temperature (T g = 300 K) without any visible sign of recrystallization. 25 This result is very interesting in view of the low aqueous solubility of this antibiotic, and it is moreover puzzling in light of the fact that an earlier study 26 on CAP has instead shown that recrystallization above T g proceeds so fast that complete crystallization is 5 observed in calorimetry thermograms obtained while heating from the glass state at a rate of 10 K/min already at T g + 25 K.
Recrystallization of a supercooled liquid can be hindered through spatial frustration, since in such case the molecules cannot aggregate to form an ordered structure. For example, twocomponent amorphous mixtures have been shown to remain stable even at temperatures where both pure components recrystallize (the first studies of binary mixtures go back to the 1960's 27, 28 ). The authors of the afore-mentioned recent study of kinetically stable supercooled liquid samples of CAP have proposed that the metastability of their samples may be due to spatial frustration associated with the presence, in the sample, of different tautomeric forms of the drug. 25 We show here that the observed metastability of CAP is indeed due to spatial frustration, but that it is due to the presence of hydrolysis products. We find evidence for the same tautomeric transformations also in supercooled liquid samples of CAP that do crystallize.
We find that recrystallization of pure CAP takes place on the timescale of hours at temperatures higher than T g . At room temperature (just below T g ) glassy CAP is found to crystallize in a timespan of days, which indicates that refrigeration would be needed to prevent the amorphous drug to crystallize. The crystallization kinetics follows the Avrami law with exponent n equal to 1.3, corresponding to one-dimensional (fibrillar) growth with only sporadic nucleation. On the other hand, we show that the metastability of amorphous CAP can indeed be tuned employing different strategies. We find that humid CAP degrades when heated above its melting temperature (degradation of CAP was previously observed when the drug was exposed to chlorine and UV radiation or in aqueous media 29, 30, 31, 32, 33 ). The resulting glass, which is in fact a mixture of CAP and degradation products, does not seem to crystallize over short times.
These findings can rationalize the recent report of a lack of recrystallization of supercooled 6 liquid CAP. 25 If it can be shown that the hydrolysis products are unharmful, then this strategy may be a simple and viable one to obtain kinetically stable amorphous CAP samples. We show moreover that CAP remains amorphous also when mixed with a biocompatible polymer such as polylactic acid, likely due to spatial frustration.
Materials and Methods
Chloramphenicol (C 11 H 12 Cl 2 N 2 O 5 , M w =323.13 g/mol) was purchased from Sigma-Aldrich with a purity higher than 98% and stored in air at ambient temperature. Three types of CAP samples were measured. In one case the CAP powder was initially dried in a vacuum oven for 24 h at room temperature and then melted and rapidly cooled to obtain a glass. In the second case, the powder was melted directly after retrieval from its storage bottle in air. In order to check the effect of water on crystallization, a third type of CAP sample was prepared by melting an ovendried sample and then allowing it to crystallize in water-vapor saturated atmosphere. For broadband dielectric spectroscopy (BDS) experiments, the powder was melted directly between the stainless steel electrodes of the capacitor (details are given in the following paragraph) and cooled at a rate of approximately 10 K/min. For differential scanning calorimetry (DSC) experiments, the powder was either melted directly during the first DSC scan (first and second type), or melted outside in the DSC pan (third type). Finally, binary mixtures of CAP with polylactic acid (PLA) were obtained by dissolving PLA (grade 4032D, from Natureworks LLC, USA, a semi-crystalline material with a concentration of D enantiomers less than 2%), in chloroform and letting it dissolve overnight using a magnetic stirrer at 310 K. The correct amount of CAP to achieve a drug loading of 20wt-% in PLA was then dissolved in acetone and such solution was then mixed with the PLA/chloroform mixture. Films were prepared by solvent casting directly on metal disk electrodes, followed by heating to 433 K to allowall solvents to 7 evaporate and to melt the crystalline fraction of PLA formed during solvent evaporation.
Characterization by X-ray diffraction showed the obtained mixture to be amorphous, and to remain so during long periods of time of storage at room temperature.
Differential scanning calorimetry (DSC) experiments were carried out on different CAP samples in open aluminum pans (diameter 4 mm) under nitrogen atmosphere, by means of a Q100 calorimeter from TA Instruments. Measurements were performed using a heating/cooling rate of 10 K/min and drug mass around 10 mg.
Infrared absorption spectra were recorded in the 4000-600 cm − 1 range with a Fourier Transform FTIR 4100 Jasco spectrometer equipped with a Specac model MKII Golden Gate attenuated total reflection (ATR) cell.
A Novocontrol Alpha analyzer was used for broadband dielectric spectroscopy (BDS) measurements. The sample was placed in a stainless steel parallel-plate capacitor (diameter of 1.2 cm) specially designed for the analysis of liquid samples, with the two electrodes kept at fixed distance by means of silica spacers of 50 μm diameter. Temperature control of the capacitor and thus of the sample was achieved with a nitrogen-gas flow cryostat with an error not higher than 0.3 K. Two different types of BDS experiments were carried out, in order to study the relaxation dynamics and the crystallization kinetics of the material. In the first case, the previously dried or as-stored polycrystalline powder sample was placed in the capacitor, melted at 423 K and quenched to cryogenic temperature inside the cryostat. Successive isothermal measurements were done every 10 K, from 133.2 to 233.2 K, every 5K, from 243.2 to 298.2 K, every 2 K, from 303.2 to 328.2 K, and again every 5 K, from 333.2 to 373.2 K. All measurements were done in the frequency (ν) range between 10 −2 and 10 6 Hz.
The second type of BDS experiment, designed to study the isothermal crystallization kinetics of CAP, consisted of measuring the decrease of strength of the dielectric loss as a function of time during the crystallization of the supercooled material at different (fixed) temperatures. To this end, the molten sample was placed inside a precooled cryostat at 293.2 K (i.e., about 8K below T g ) and then the temperature was raised at a rate of 10 K/min until reaching the desired isothermal crystallization temperature. We measured the recrystallization at five distinct temperatures between 319 and 335 K by acquiring several dielectric spectra one after another, in the frequency range from 1 to 10 6 Hz. A freshly prepared sample was used for each isothermal recrystallization experiment.
To obtain relaxation time values and quantify the changes in relaxation dynamics, we fitted the dielectric spectra (real and imaginary part simultaneously) with a power law for the conductivity contribution and a superposition of Havriliak-Negami functions 34, 35 for the relaxation peaks. The analytical expression of the Havriliak-Negami function is:
Hereω = 2πν is the angular frequency,ε ∞ is the permittivity in the high frequency limit, Δε is the dielectric strength, the exponents a and b (which may vary between 0 and 1) describe the symmetric and asymmetric broadening of the peak, respectively, and τ HN is a time parameter connected to the characteristic relaxation time τ max, corresponding to the maximum of the relaxation time distribution. τ max was calculated from the fitting parameters as:
Specific cases of this relaxation are the Cole-Cole (CC) 36 and Cole-Davidson (CD) 37 relaxations, which are obtained for b = 1 and a = 1, respectively. For both cases τ max = τ HN . Most secondary peaks are broad but symmetric, and are often described with the Cole-Cole function.
Results and Discussion
The blue line in Figure 1a represents the DSC thermogram of the pure (vacuum-dried) CAP powder, measured upon heating. The observed onset of melting is 422 ± 1 K, in agreement with previous findings, 26 with a enthalpy of fusion of 103 ± 3 J/g. X-ray diffraction patterns of the vacuum-dried powder are in agreement with previous findings. 38 The glass transition temperature, identified in the second heat-up scan acquired after cooling the melted sample ( Figure 1b ), is 300 ± 2 K. No recrystallization peak is detected, in contrast with an earlier calorimetry study. 26 that no hydrate phase 39 was formed in the sample recrystallized in water saturated atmosphere.
The lower melting point and enthalpy observed in Figure 1a are likely due to a decrease of the purity of the sample. Full recrystallization was observed also in glassy samples stored in air at room temperature over a period of few days. These results confirm that cold recrystallization of CAP is possible even in the glassy state, that is, that glassy CAP is unstable against the formation of the crystal phase.
We employed dielectric spectroscopy to study the molecular relaxation dynamics of amorphous CAP (both in the supercooled liquid and glassy state). The vacuum-dried CAP powder was melted and fast-cooled to 133 K, and isothermal spectra were then acquired by stepwise increasing the temperature. Figure 2 shows the dielectric loss spectra at selected temperatures. Panel b shows the spectra above room temperature, in which the structural relaxation is visible on top of a conductivity background which increases towards low frequencies. This relaxation is the-so called primary α process, which corresponds to the cooperative motion of CAP molecules and is associated with the glass transition. The peak maximum of the α relaxation moves to lower frequencies the lower the temperature, indicating decreasing molecular mobility with decreasing thermal energy, and it is below 0.01 Hz for T < 302 K, in agreement with the calorimetric T g . 26 Figure 2a shows the spectra below T g , where a secondary (γ) relaxation much less intense than the α process is observed. The relaxation times of both processes are displayed as Arrhenius plot in Figure 3 . The inset to be seen that the relaxation strength of the α process scales as 1/T, as expected from the Kirkwood-Fröhlich equation. 34 The secondary relaxation is a simply-activated process, following the Arrhenius law with activation energy E a = 38.0 ± 0.6 kJ/mol, a relatively low value which is close to that reported in ref 25 and which suggests an intramolecular origin of this relaxation process, 40 as also discussed below. Instead, the temperature dependence of the α relaxation time could be modeled with a Vogel-Fulcher-Tamman (VFT) function, defined by:
Here τ ∞ is the high temperature limit of the relaxation time, D is the so-called strength parameter (proportional to the inverse of the fragility index, see below) and T 0 is the Vogel-Fulcher temperature, whose value indicates the departure from a simply-activated behavior. The The relaxation dynamics could not be explored at higher temperature. At 315 K, in fact, a clear decrease of the loss peak maximum is visible (Figure 2b) , indicative of the occurrence of recrystallization. The intensity of the relaxation (dielectric strength) is directly proportional to the number of relaxing dipoles in the sample 34 and recrystallization implies loss of orientational motions. Since the viscosity is lower at higher temperatures, recrystallization, whose kinetics is mostly governed by molecular diffusion, is more likely to take place above T g . This rationalizes the fact that the decrease in dielectric strength is only observed at high temperatures, where crystallite nucleation and growth take place and molecular dipoles become immobilized. 41, 42 We performed isothermal recrystallization measurements to investigate the characteristic timescale and mechanism of crystal growth from the supercooled liquid phase. Figure 4 show Assuming a temporal dependence of recrystallization as described by Avrami, 45, 46 ε n is given by: 47
Here, t o is the onset (induction) time of nucleation, K is the rate of recrystallization and n is the Avrami exponent which depends only on the morphology of crystallites and the mechanism of the recrystallization process. 48 The value of t o is estimated taking the intercept of the horizontal plateau of Δε at short times with the tangent to the decreasing portion of the graph of Δε (see Figure 5a ). Figure 5b shows the plot of ln(-ln(1-ε n )) versus ln(t- reported also in previous studies on the as-synthesized CAP powder. 49 The inset of Figure 5b shows the relation between Logτ α and Log(t c -t o ), where t c is the characteristic crystal growth time, defined as the time at which ε n becomes equal to 0.25. Though not precise, the linear regression gives a slope value of 0.6 ± 0.1. This correlation between the structural relaxation time and the time of crystallization has been observed before (albeit with a slightly different slope) in several systems, for example in the case of stiripentol 20 and of indomethacine and celecoxib, 50 and also in binary mixtures of pharmaceutical compounds and 20 polymeric excipients. 51 The correlation between crystal growth rate and mobility (or equivalently, viscosity) above T g appears to be a general feature of glass formers (also nonpharmaceutical ones), 41 , 52 , 53 related to the fact that the crystallization rate is kinetically driven near the glass transition temperature.
As mentioned, previous dielectric measurements 25 at ambient pressure showed no recrystallization of CAP, which was ascribed to the effect of conformational changes (tautomerization) in the supercooled liquid sample. The authors of this previous study report that no crystallization takes place at 323 K during at least two and a half days, and they report that no crystallization takes place at 338 K during at least three hours. Instead, Figure 5 shows that pure CAP crystallizes relatively fast at 324 K, and our experiments at 335 K (not shown) indicate that crystallization at this temperature is so fast that it starts well before reaching the isothermal temperature conditions. As we show in the following, the most likely explanation of the failure of CAP to recrystallize in the experiments reported in ref 25 is its partial degradation.
Previous studies have shown that CAP has two main degradation pathways, namely, amide hydrolysis and carbon-chlorine cleavage. 29, 30, 31, 32 In the former case the reaction is acid-base catalyzed (though its rate does not depend on the pH of the concentration) while in the latter case, pH and temperature play a significant role. In the former case, the products of degradation are 1-(p-nitrophenyl)-2-amino-propanediol and dichloroacetic acid, while in the latter case they are a Cl-substituted alcohol CAP derivative and (at least partially) dissociated hidrochloric acid, 30 but other secondary pathways that lead to degradation may exist. 29 Furthermore it was reported that, while water-free preparations show no sign of degradation (pure CAP does not degrade upon melting 54 ), detectable amounts of these degradation products are present in aqueous solutions as well as in preparations of CAP with relatively low amounts of water (e.g.,
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condensed from humid air). Recent studies 55, 56 report that the half-life of CAP in water at 333 K is of the order of 20 days, and that in boiling water CAP exhibits 12% degradation in 1 hour.
Dielectric measurements on the as-stored CAP powder (without prior drying in the vacuum oven) indicate that it indeed does not recrystallize, or else recrystallizes at a much slower rate, than the pure (vacuum dried) material. Figure 6a shows isothermal dielectric measurements at 324 Kon a supercooled liquid sample of CAP melted at 433 K directly after retrieval from the storage bottle (in air). After 768 min, Δε as detected from the real permittivity spectra is lowered by only 5% with respect to its value at the beginning of the experiment, while no clear difference is detected in the imaginary permittivity (loss) spectra. After 977 min a slight difference is observed in the loss spectra, and Δε is lowered only by 8%.This is clearly in contrast to what is observed in Figures 4 and 5: for example, when the vacuum-dried sample is melted at 423 K, isothermal crystallization at 324 K starts already after an induction time t o = 230 min. 
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A possible rationale for the hindering of recrystallization could be that heating the initially water containing powder leads to partial degradation, and that the products of degradation impede the ordering of the CAP molecules into a crystalline phase. In other words, just like many binary mixtures fail to recrystallize due to the extremely slow formation kinetics (or lack) of a co-crystal phase, it can be expected that CAP does not recrystallize when mixed with the products of degradation such as for example the 1-(p-nitrophenyl)-2-amino-propanediol molecules. The occurrence of partial degradation was confirmed by direct observation of the sample at the end of the experiment: while pure CAP is white, the outcome of melting the asstored CAP sample was a viscous yellow-brownish liquid, with a color similar to that previously reported for sunlight degraded CAP. 29 To analyze the outcome of degradation, we have recorded the FTIR spectrum of the degraded sample (after annealing for 3600 s at 433 K) and compared it to the spectrum of the pure (vacuum-dried) sample. As can be seen from Figure 7 , the amide A (3130-3500 cm -1 ) and amide II (around 1500 cm -1 ) bands were modified after annealing, with the degraded sample showing much broader and less defined peaks. The first amide band shows clearly how hydrogen bonding network is affected by the high temperature treatment, as the two defined peaks that are visible in the pure sample at 3258 and 3343 cm -1 merge into a broader and wider band.
We therefore suggest that the observed stability of supercooled CAP obtained by melting the as-stored powder is indeed due to spatial frustration, but not due to the presence of different tautomers, as suggested in ref 25 , and instead due to the presence of hydrolysis products.
Tautomerization transformations are observed also in pure (non-degraded) CAP, and they result in samples that crystallize above T g over relatively short periods of time. Hence it would appear that the presence of different tautomers is not an impediment for nucleation of the crystal phase. sample. This sample displayed the same primary and secondary relaxation as pure CAP ( Figure   8a ). As can be seen from Figure 6b , the loss spectrum of the degraded sample was characterized by a higher conductivity, most likely due to charged products of the water-induced partial decomposition (such as protons and hydroxyl and chlorine anions), which lowers the visibility of the structural relaxation peak. In order to allow a better comparison of the spectra, the inset of The dc conductivity of the partially degraded sample is significantly higher, it does not exhibit a monotonic behavior (in fact, it decreases above 384K), and, as visible in the inset to Figure 7b , it does not scale linearly with the cooperative relaxation time (rather, it displays a power law correlation with it, referred to fractional Stokes-Einstein rule 61 ). These last two observations suggest that the conductivity enhancement is due to relatively small, ionic species (for example, chlorine ions, hydroxyl ions, or protons) whose diffusion is decoupled from the structural relaxation of the much bulkier CAP molecules, 62 and which likely recombine into neutral species upon heating to above approximately 380 K. Other glass-forming systems show a decoupling of ion conduction and structural relaxation, in particular ionic liquids, where various processes are responsible for conduction. 63 Even though the partially degraded pharmaceutical is stable in the amorphous phase, another approach should be taken to stabilize the amorphous form of CAP, so as to take advantage of its better dissolution profile with respect to the crystalline form, and at the same time avoid the potential toxicity of the degradation products. A strategy that suggests itself in the case of CAP is to mix it with another (biocompatible) substance that could induce spatial frustration as in the partially degraded sample. 64 To demonstrate the feasibility of this approach, we dispersed CAP (20% in weight) in a commercial biopolymer, namely poly-lactic acid (PLA), which due to its biocompatibility, degradation into natural metabolites and low cost, is one of the most widely used materials in biomedical applications. 65, 66 The left inset to Figure 9 shows the DSC thermogram of the resulting amorphous solid-state dispersion, whose T g is observed to be 316 K, in between the T g of pure PLA (332 K) and that of CAP (302 K). At higher temperature, only the recrystallization and subsequent melting of PLA can be seen. Interestingly, both the T g and melting temperature of PLA seem to be affected by the presence of the drug. The onset of PLA recrystallization occurs at relatively high temperature (ca. 380 K), hence it does not affect the storage and metastability of the amorphous pharmaceutical at ambient temperature. As visible in the dielectric spectra displayed in Figure 9 , at a given temperature the structural relaxation peak of the mixture is observed at a frequency in between the peak of pure PLA and the peak of pure CAP, as expected from the observed variation in T g . No phase separation is observed: only one T g is detected in DSC, and only one structural loss peak is observed in BDS. The right inset of Figure 9 shows the Arrhenius plot for the three samples, where again the relaxation times of the dispersion are seen to lie in between the relaxation times of the polymer and of pure CAP. This totally amorphous and homogeneous sample was stable at ambient temperature for at least a few weeks. , however, the spatial frustration is not a consequence of different tautomers but rather of hydrolysis products. If these can be shown not to be harmful, then melting and cooling CAP powder exposed to air can be employed as a straightforward and facile approach to obtain kinetically stable amorphous CAP. We further explored the effect of spatial frustration by dispersing CAP in poly-lactic acid: the structural relaxation time and T g of the resulting mixture are intermediate between those of the two pure components, and the dispersion is found to be stable in the amorphous phase for relatively long periods of time.
